Skip to content 
Semaglutide or Zepbound®: Navigating the landscape of GLP-1’s
Table of Contents 1. Introduction The landscape of medical treatment for chronic conditions such as type 2 diabetes and obesity has evolved dramatically in the last few decades. With the global burden of these diseases escalating, the search for effective therapeutic options has become a priority in healthcare research and development. Among the notable advancements …